Bicycle Therapeutics PLC (NASDAQ:BCYC)

25.50
Delayed Data
As of Jun 06
 -0.45 / -1.73%
Today’s Change
12.08
Today|||52-Week Range
33.49
-13.85%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$734.3M

Company Description

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Contact Information

Bicycle Therapeutics Plc
Granta Park Great Abington
Cambridge Cambridgeshire CB21 6GS
P:441223261503
Investor Relations:
(617) 447-3948

Employees

Shareholders

Other institutional66.84%
Mutual fund holders19.22%
Individual stakeholders--

Top Executives

Kevin LeeChief Executive Officer & Executive Director
Lee H. KalowskiPresident & Chief Financial Officer
Alistair MilnesChief Operating Officer
Michael SkynnerChief Technology Officer
Nicholas KeenChief Scientific Officer